Aerovate Therapeutics, Inc. License Agreements
2 Contracts & Agreements
- Cell Line License Agreement, effective October 22, 2024, by and between WuXi Biologics Ireland Limited and Jade Biosciences, Inc (Filed With SEC on December 3, 2024)
- APRIL License Agreement, dated October 30, 2024, by and between Paragon Therapeutics, Inc. and Jade Biosciences, Inc (Filed With SEC on December 3, 2024)
